Recreational drug toxicity

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 8, Issue 1, 2008, Pages 99-103

  Hill, Simon ^a   Thomas, Simon H L ^a,b  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; AMPHETAMINE; ANTIDIARRHEAL AGENT; BARBITURIC ACID DERIVATIVE; BICARBONATE; CANNABIS; COCAINE; CODEINE; DANTROLENE; DIAMORPHINE; DIAZEPAM; DIHYDROCODEINE; FLUMAZENIL; FLUNITRAZEPAM; GLYCERYL TRINITRATE; ILLICIT DRUG; KETAMINE; LORAZEPAM; LYSERGIDE; METHADONE; MORPHINE; OPIATE; PIPERAZINE; RECREATIONAL DRUG; TEMAZEPAM; ZOLPIDEM;

ACIDOSIS; CLINICAL FEATURE; DRUG ABUSE; DRUG INTOXICATION; HUMAN; HYPERTENSION; MORTALITY; REVIEW; SYMPTOMATOLOGY; TACHYCARDIA;

EID: 39149123169     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.8-1-99     Document Type: Review

References (15)

1. National Statistics for Health and Social Care. Statistics on drug misuse, England, 2007. www.ic.nhs.uk/pubs/drugmisuse07
2. Morgan O, Griffiths C, Toson B et al. Trends in deaths related to drug misuse in England and Wales, 1993-2004. Health Stat Q 2006;31:23-7.
3. Advisory Council on the Misuse of Drugs. The classification of cannabis under the Misuse of Drugs Act 1971. Available at: drugs.homeoffice.gov.uk/publication-search/acmd/cannabis-class-misuse-drugs-act? view=Binary (last accessed 2 October 2007).
4. Treadwell SD, Robinson TG. Cocaine use and stroke. Postgrad Med J 2007;83:389-94.
5. Mokhlesi B, Leikin JB, Murray P, Corbridge TC. Adult toxicology in critical care. Part II: specific poisonings. Chest 2003;123:897-922.
6. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy'). Lancet 1992; 340:384-7.
7. Hahn IH, Hoffman RS. Cocaine use and acute myocardial infarction. Emerg Med Clin North Am 2001;19:493-510.
8. Hollander JE. Cocaine-associated myocardial infarction. J R Soc Med 1996;89: 443-7.
9. Khan LA, Nair CK. Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002;122:311-28.
10. Gee P, Richardson S, Woltersdorf W, Moore G. Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand. N Z Med J 2005;118:U1784.
11. Wood DM, Dargan PI, Button J et al. Collapse, reported seizure - and an unexpected pill. Lancet 2007;369:1490.
12. Sporer KA. Acute heroin overdose. Ann Intern Med 1999;130:584-90.
13. Justo D, Gal-Oz A, Paran Y, Goldin Y, Zeltser D. Methadone-associated torsades de pointes (polymorphic ventricular tachycardia) in opioid-dependent patients. Addiction 2006;101:1333-8.
14. National Collaborating Centre for Mental Health. The short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care. Leicester, London: British Psychological Society, Royal College of Psychiatrists, 2004. www.bps.org.uk/ downloadfile.cfm?file_uuid=C11587F1-7E96-C67F-DD13-357E1AA3B75D&ext =pdf (last accessed 2 October 2007)
15. Caldicott DG, Chow FY, Burns BJ, Felgate PD, Byard RW. Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia. Med J Aust 2004; 181:310-3.